PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31713675 ↗2019Reported benefit

Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.

RatChemical/toxinSprague-DawleyMaleOral gavagePretreatment: administered for 1 week before injury, with D-galactosamine given…

Model: Acute liver injury induced by intraperitoneal injection of D-galactosamine on day 8, with sampling 24 h later

Pretreatment attenuated elevations in aminotransferases, bilirubin and total bile acids and reduced histological hepatic injury. It was anti-inflammatory, downregulating hepatic Toll-like receptors, TNF-alpha and NF-kappa B transcription and lowering plasma proinflammatory cytokines, and it amelior…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.